Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study

Marielle S. Klein Hesselink, Marloes Nies, Gianni Bocca, Adrienne H. Brouwers, Johannes G. M. Burgerhof, Eveline W. C. M. van Dam, Bas Havekes, Marry M. van den Heuvel-Eibrink, Eleonora P. M. Corssmit, Leontien C. M. Kremer, Romana T. Netea-Maier, Heleen J. H. van der Pal, Robin P. Peeters, Kurt W. Schmid, Johannes W A Smit, Graham R. Williams, John T. M. Plukker, Cecile M. Ronckers, Hanneke M. van Santen, Wim J. E. TissingThera P. Links*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Introduction: Treatment for differentiated thyroid carcinoma (DTC) in pediatric patients is based mainly on evidence from adult series due to lack of data from pediatric cohorts. Our objective was to evaluate presentation, treatment-related complications, and long-term outcome in patients with pediatric DTC in The Netherlands. Patients and Methods: In this nationwide study, presentation, complications, and outcome of patients with pediatric DTC (age at diagnosis
Original languageEnglish
Pages (from-to)2031-2039
JournalJournal of Clinical Endocrinology & Metabolism
Issue number5
Publication statusPublished - May 2016

Cite this